Puma Biotechnology Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2007
Cash & Equivalents	84.59	76.2	71.98	94.14	68.89	108.42	86.02	198.81	35.88	39.75	Upgrade
Short-Term Investments	11.35	4.87	18.98	8.1	51.61	57	0	34.98	184.32	102.79	Upgrade
Cash & Cash Equivalents	95.94	81.07	90.96	102.24	120.49	165.42	86.02	233.79	220.2	142.54	Upgrade
Cash Growth	18.34%	-10.86%	-11.04%	-15.15%	-27.16%	92.32%	-63.21%	6.17%	54.48%	67.38%	Upgrade
Receivables	47.84	40.35	32.53	25.54	28.9	20.77	9.67	0	0	1.76	Upgrade
Inventory	7.08	4.53	7.11	3.45	3.17	2.63	2.03	0	0	0	Upgrade
Other Current Assets	5.33	8.33	9.43	14.9	13.74	14.18	8.68	2.68	3.35	5.08	Upgrade
Total Current Assets	156.19	134.28	140.02	146.14	166.3	203	106.39	236.47	223.55	149.38	Upgrade
Property, Plant & Equipment	8.65	12.51	15.77	18.89	21.83	3.96	4.47	5.15	2.38	2.16	Upgrade
Long-Term Investments	2.09	2.59	3.31	3.31	4.32	4.32	0	0	0	0	Upgrade
Goodwill and Intangibles	60.87	70.61	66.13	74.14	40.46	44.41	48.36	0	0	0	Upgrade
Other Long-Term Assets	2.73	2.07	1.35	1.75	2	3.43	6.31	11.16	13.91	11.22	Upgrade
Total Long-Term Assets	74.34	87.78	86.56	98.08	68.61	56.12	59.13	16.32	16.29	13.38	Upgrade
Total Assets	230.53	222.06	226.59	244.22	234.91	259.12	165.53	252.79	239.84	162.76	Upgrade
Accounts Payable	6.89	6.44	11.17	12.08	19.18	20.68	27.69	20.04	17.8	15	Upgrade
Current Debt	38.8	4.14	3.57	17.38	2.62	0	0	0	0	0	Upgrade
Other Current Liabilities	53.7	66.9	94.84	84.8	69.03	46.43	30.65	17.43	14.64	29.44	Upgrade
Total Current Liabilities	99.38	77.48	109.59	114.26	90.84	67.12	58.34	37.46	32.44	44.44	Upgrade
Long-Term Debt	72.69	110.14	113.07	103.57	117.61	151.89	48.48	0	0	0	Upgrade
Other Long-Term Liabilities	5.01	12.83	6.38	32.34	9	5.82	5.41	5.51	1.39	1.27	Upgrade
Total Long-Term Liabilities	77.7	122.97	119.45	135.92	126.61	157.7	53.88	5.51	1.39	1.27	Upgrade
Total Liabilities	177.09	200.45	229.03	250.17	217.44	224.82	112.22	42.97	33.84	45.71	Upgrade
Total Debt	111.49	114.28	116.64	120.95	120.23	151.89	48.48	0	0	0	Upgrade
Debt Growth	-2.44%	-2.02%	-3.57%	0.60%	-20.84%	213.32%	-	-	-	-	Upgrade
Retained Earnings	-1,345.16	-1,366.76	-1,366.76	-1,337.63	-1,277.64	-1,202.04	-1,088.47	-796.51	-520.5	-281.22	Upgrade
Comprehensive Income	-0	0	-0	0	0.06	-0.01	0	-0.01	-0.15	-0.1	Upgrade
Shareholders' Equity	53.44	21.61	-2.45	-5.95	17.46	34.31	53.3	209.82	206.01	117.05	Upgrade
Net Cash / Debt	-15.55	-33.21	-25.69	-18.72	0.27	13.54	37.54	233.79	220.2	142.54	Upgrade
Net Cash / Debt Growth	-	-	-	-	-98.04%	-63.94%	-83.94%	6.17%	54.48%	67.38%	Upgrade
Net Cash Per Share	-0.33	-0.74	-0.63	-0.47	0.01	0.36	1.01	7.02	6.85	4.75	Upgrade
Working Capital	56.8	56.8	30.44	31.88	75.46	135.89	48.05	199.01	191.11	104.94	Upgrade
Book Value Per Share	1.13	0.48	-0.06	-0.15	0.45	0.90	1.43	6.30	6.41	3.90	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).